Dr. Richard Mann

Before you continue

A note on the products

A brief, transparent disclosure before you visit the product Dr. Mann is associated with.

Dr. Richard H. Mann

Financial disclosure

Dr. Mann has a financial interest in Zobria Labs, the makers of Zobria, a patent-pending benfotiamine and vitamin B12 formulation.

The clinical publications referenced on this site describe individual patient cases and reviews of existing literature. They are not controlled clinical trials of Zobria specifically, and individual results may vary.

These statements have not been evaluated by the Food and Drug Administration. Zobria is not intended to diagnose, treat, cure, or prevent any disease.